HTAC GUIDANCE: PNF INCLUSION OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPOETIN ALFA) 4000 IU/ML SOLUTION FOR INJECTION (IV/SC) 1ML PRE-FILLED SYRINGE
HTAC GUIDANCE: PNF INCLUSION OF FILGRASTIM 300 MCG/0.9 ML SOLUTION (IV, SC), 0.9 ML PRE-FILLED SYRINGE
[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF DAPAGLIFLOZIN FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS
HTAC RECOMMENDATION ON THE PNF INCLUSION OF abiraterone acetate in combination with prednisone and enzalutamide for individuals with metastatic castration-resistant prostate cancer
HTAC RECOMMENDATION ON THE PNF INCLUSION OF REMDESIVIR FOR ADULT PATIENTS WITH COVID-19 REQUIRING HOSPITALIZATION
HTAC Recommendation for the Inclusion of Zoledronic Acid for Individuals with Malignancy-Related Bone Disease in the Philippine National Formulary (PNF)
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN COVID-19
